| Stage | DOLE | % of rev | PHR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.5B | 100.00% | $129M | 100.00% | DOLE ×19.31 |
| Gross profit | $195M | 7.81% | $110M | 85.11% | PHR +77.3pp |
| Operating income | $47M | 1.90% | $8M | 5.88% | PHR +4.0pp |
| Pre-tax income | $41M | 1.64% | $3M | 2.50% | PHR +0.9pp |
| Net income | $35M | 1.41% | $2M | 1.48% | PHR +0.1pp |
| Stage | DOLE | PHR | Gap · A − B |
|---|---|---|---|
| Revenue | $2.5B100.00% | $129M100.00% | DOLE ×19.31 |
| Gross profit | 7.81%$195M | 85.11%$110M | PHR +77.3pp |
| Operating income | 1.90%$47M | 5.88%$8M | PHR +4.0pp |
| Pre-tax income | 1.64%$41M | 2.50%$3M | PHR +0.9pp |
| Net income |
| 1.41%$35M |
| 1.48%$2M |
| PHR +0.1pp |
No shared counterparties.